Quantcast

Latest Nektar Stories

2014-08-28 08:25:55

NEW YORK, Aug. 28, 2014 /PRNewswire/ -- Jeremy B. Edelman, President and Founder of Nektar Naturals Fine Foods announced today that Fields Texas Ltd. and Argo Capital Partners have made a minority equity investment in the company, creating a strategic alliance that will serve to assist in driving retail expansion nationally over the next 12 months and expand the company's product offerings. Photo - http://photos.prnewswire.com/prnh/20140827/140780 Photo -...

2014-07-31 16:29:07

SAN FRANCISCO, July 31, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2014. Cash and investments in marketable securities at June 30, 2014 were $301.4 million as compared to $309.1 million at March 31, 2014. "The second half of 2014 will be an exciting time for Nektar as we look forward to significant milestones for a number of our late-stage clinical programs," said Howard W. Robin, President and Chief...

2014-07-22 20:22:40

SAN FRANCISCO, July 22, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2014 on Thursday, July 31, 2014, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference call can be...

2014-05-19 08:28:29

SAN FRANCISCO, May 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, announced that Ivan Gergel, M.D., will serve as the Company's new Senior Vice President, Drug Development & Chief Medical Officer effective today. Dr. Gergel will have oversight for the company's clinical strategy and activities, including direct supervision of clinical research, clinical operations, medical affairs, regulatory...

2014-05-01 16:33:20

SAN FRANCISCO, May 1, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter ended March 31, 2014 on Wednesday, May 7, 2014, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference call can be...

2014-02-19 16:24:58

SAN FRANCISCO, Feb. 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2013 on Wednesday, February 26, 2014, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the...

2014-01-23 00:20:53

SAN FRANCISCO, Jan. 22, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) ("Nektar") today announced the pricing of its previously announced underwritten public offering of 8,500,000 shares of its common stock at a public offering price of $12.75 per share. In connection with this offering, Nektar has also granted to the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock. J.P. Morgan and Jefferies are acting as joint book-running...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'